Merck sucks at launching new drugs

Merck is consistently getting killed by the competition when it comes to launching new drugs. Opdivo is on track to outsell Keytruda by a large margin, Avycaz is outselling Zerbaxa, and the Belsomra launch is a disaster. Despite the lower price, the Zepatier launch will be no different and it will get but a small fraction of the Hep C market from Gilead or Abbvie. The days of Merck dominating in any therapeutic are are long gone. It's a shame what mother Merck has turned this company into.

 

PC here. You are so right. Add to the list: Dulera, Janumet XR, Liptruzet, Juvisync, the list goes on and on. Not sure which is worse, R&D or Marketing. We must have a lot of cash to be able to keep cranking out these disappointments and yet stay in business.

 

On the Vaccine side they really botched up the launch and continued marketing of Zostavax. Adults and primary care doctors don't care about this shingles vaccines which is basically 50% effective. On top of that, Merck allowed the purchasing and reimbursement process to become difficult which really put off patient and doctors. Our pitchman, Terry Bradshaw can't even save us. Many of the good reps have been forced out or moved on but Merck kept many of the same idiots in leadership roles who gave us the VIOXX debacle. Is it any wonder why the company is a shell of what it was?

 

If you think Merck ever dominated HCV with peg intron, your have revisionist history. The only domination in this disease was when you launched it before pegasys. Victrelis sucked and your decision to have the Pegasys reps "educate" treaters about it was a miscalculated joke, we threw a few key words to the docs and then discuss using incevik in combo. What magic are you going to create this time???!!!

 

Grastek, Ragwitek, Zontivity.....

6 years ago, these were among the "blockbusters" on the pipeline chart that would be "game changers" for Merck's growth trajectory.

Guess they were right.

 

Sounds like recovery meetings may be in order if the sales projections at launch are not being met. Recovery meetings have always improved sales performance whenever they have been implemented. It's always extremely motivational to see Merck managers and directors bring reps to tears. Call me a sadist but I find recovery meetings to be mostly full of fun.

 

We need the right reps in the right places. I think we should hold a 'caucus event' for each district. Bring the reps into a room and place them according to skills and experience. Sorry to the mom that may have to do overnights or the dad that will be driving more each day. This 'where you live' crap has got to go. This caucus event would apply to ctl's too, bad reputation and you are gone like the wind.

 

This Pegasys rep is telling the truth. Merck totally miscalculated when they partnered with Roche. It only made Merck look weak and doctors knew it. The new products pi looks like it will be a tough sell and will have a more limited viability than Gilead's pi does. I don't think that Merck is capable of pulling a rabbit out of the hat in order to compete any more. They just aren't the juggernaut that has the respect of physicians now.

 

Keeping the same losing executives who brought you VIOXX doesn't help.

 

Or more importantly keeping the same loser directors that launched Victrells to launch the new hep c drug as well as some of the same managers. Brilliant idea. "Albert Einstein said the definition of insanity is doing something over and over again and expecting the same result. Obviously Merck has not gotten the memo.

 

They still have the same director and some of the same managers in the hep c /hiv division. Albert Einstein said the definition of insanity is doing something over and over again and expecting
different results. They lost last time and they will lose again. Same management will get the same results.

 

I think you meant expecting a different result.

 

Just one CTL's opinion here, most here at Merck are longtime employees that are fat and happy and there is little to no incentive to be at our best. We have high salaries, pension, low bonus and no stock and are often competing against companies that offer higher salaries, higher bonus, and stock options. It is the complacent versus the motivated, guess who wins?

 

I will solve your riddle-The Ctls win. They get off managing reps out of mother MRK. Soon these fukstick managers will be in the bread line and no one will hire them. They have terrorized reps for years and will be lucky if they get an Inventiv REP job after MRK. FU.

 

I enjoy riding the useless out of this very fine company especially the scums, bumbs, 15s dorks and twerks. I make Hugh salary, stock options and many many perks. Losers!

 

Add to this the fact that due to previous transgressions we are limited in our activities through no less that 2 dozen compliance policies that include threats of disciplinary action up to and including termination. No wonder majority of reps operate with minimal motivation. As long as a rep can get through a day without a policy violation, it has been a successful day. The irony is that the less you do, the less likely you are to be at risk for a violation.

 

bump

 

You're not a sadist. You're an idiot

 

No your moronic CTL. What have you been listening too and reading? We don't have high salaries-other companies do pay more. But that what Merck has been telling you all along so you believe it you robot. Pension? Yes, others have that too. Low bonus? correct. No stock? correct. Its called PC. Thats why we don't sell. Nothing to do with being fat and happy. Lots of us are depressed because we don't do all we can do to sell because of fear of retaliation or losing our jobs. Retaliation you say? We don't have any of that! Bullshit we don't.

You CTL's-you bring nothing of value to the table on FV's. You might think you do, but you don't. We and the customers we call on all talk about you when you leave. Youre nothing but a pain in the ass, and thats it. Get it straight.

 

this place sucks ass so bad you can taste it